Results 21 to 30 of about 9,407 (166)
Toxicology Reports, 2014 Piroxicam (chemically 4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide), a classical non-steroidal anti-inflammatory drug (NSAID) is orally administered to arthritic patients.
Syed Benazir Firdaus +13 more
doaj +1 more source
Comparison of Analgesic Effect of Rosmarinic Acid With Piroxicam in Mice [PDF]
International Journal of Basic Science in Medicine, 2022 Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most widely used drugs in the treatment of pain and inflammation. Although, their side effects i.e.; gastrointestinal and renal adverse effects, limit the use of these drugs ...
Mohsen Moradi +6 more
doaj +1 more source
Comparison of Efficacy and Safety of Intramuscular Piroxicam and Tramadol for Post-operative Pain in Patients Undergoing Caesarean Delivery [PDF]
Journal of Clinical and Diagnostic Research, 2016 Introduction: Post-caesarean section pain can be both stressful and unfavourable. Effective and rapid reduction of pain facilitates early ambulation and care of the new born.
Tejashree Thippeswamy +3 more
doaj +1 more source
Cocrystals of Piroxicam with Carboxylic Acids
, 2016 A crystal engineering method was used to investigate cocrystal formation of piroxicam with pharmaceutically acceptable carboxylic acids. Forming cocrystals of piroxicam can potentially result in solid forms with increased bioavailability.
Scott L. Childs (1333299) +1 more
core +2 more sources
Synthesis and biological evaluation of Piroxicam derivative as a lead chelator
Main Group Metal Chemistry, 2019 Lead as a potent environmental and occupational pollutant, exerts its toxic effect mainly through oxidative stress induction. Currently, chelation therapy is the only medical management of metal intoxications in clinic, but its administration is ...
Hosseini Sayed Masoud +4 more
doaj +1 more source
Neural Regeneration Research, 2015 Our previous studies indicated an increase in extracellular γ-aminobutyric acid (GABA) in rodent′s ischemic brain after Piroxicam administration, leading to alleviation of glutamate mediated excitotoxicity through activation of type A GABA receptor ...
Pallab Bhattacharya +3 more
doaj +1 more source
Pharmaceutics, 2010 Several biologically relevant phospholipids were assessed as potential carriers/additives for rapidly dissolving solid formulations of piroxicam (Biopharmaceutics Classification System Class II drug).
Muhammad D. Hussain +4 more
doaj +1 more source
FORMULATION AND PHYSICOCHEMICAL CHARACTERIZATION OF PIROXICAM CONTAINING POLYMER FILMS [PDF]
Bulletin of Pharmaceutical Sciences. Assiut University, 2010 Piroxicam is a potent nonsteroidal anti-inflammatory drug associated with many side effects when taken orally. An attention was paid in this work to formulate and characterize piroxicam containing polymer films for dermal use.
Sayed H. Auda +3 more
doaj +1 more source
Biomedical Applications of Thermosensitive Hydrogels for Controlled/Modulated Piroxicam Delivery
Gels, 2023 The objectives of this study are the synthesis of thermosensitive poly(N-isopropylacrylamide-co-2-hydroxypropyl methacrylate), p(NiPAm-HPMet), hydrogels and the analysis of a drug-delivery system based on piroxicam, as a model drug, and synthesized ...
Snežana Ilić-Stojanović +5 more
doaj +1 more source
Atividade ulcerogênica do celecoxibe, piroxicam e piroxicam associado a sulfato de zinco em modelo de granuloma em ratos [PDF]
, 2010 OBJETIVOS: Objetivou-se neste estudo, avaliar a atividade ulcerogênica do celecoxibe (seletivo para COX-2), do piroxicam e piroxicam+sulfato de zinco (AINEs não seletivos).
Fabiana Gatti De Menezes +3 more
core +3 more sources